Analyses and modeling of ovarian cancer microarray data

Download

index.pdf

Date

2019

Author

Karakelle, Barış S

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

304
views

117
downloads

Ovarian cancer is one of the common cancer types among other oncological diseases. The major causes of this cancer can be listed as age, obesity, hormone therapy, material inheritance and contraceptive pills. Due to its generality and importance, many researches have been conducted from distinct labs about this illness and its plausible causes have been intensively investigated either inmicroarray studies, where just part of the related genes are detected, or in thepairwise correlation analyses between the disease and selected symptoms via contingency tables. Hereby, in this study, we use an ovarian cancer microarray dataset and describe gene interactions in these data via two different modelling approaches, namely, Gaussian graphical model as a parametric model and artificial neural network as a nonparametric model. From these analyses, we evaluate certain findings biologically and then, compare the performance of the model accuracies in distinct accuracies measures by controlling the true network structures of selected genes. By this way, we aim to assess the performance of these two fundamental models by using this specific oncogene data.

Subject Keywords

Ovaries, Ovaries Cancer., Ovarian Cancer, Microarray, Gaussian Graphical Model, Neural Network.

URI

http://etd.lib.metu.edu.tr/upload/12625004/index.pdf
https://hdl.handle.net/11511/45181

Collections

Graduate School of Natural and Applied Sciences, Thesis

Suggestions

OpenMETU
Core

Cancer modeling via biologically validated genes Karakelle, Barış Su; Purutçuoğlu Gazi, Vilda; Ürün, Yüksel (2017-05-10) The cancer disease is the second most common disease type seen after the frequency of the cardiovascular diseases. The frequency of this genetic disease changes with respect to the gender. Accordingly, the gynecological cancer, which covers ovarian, endometrial or cervical cancer, is the second most common cancer type in women after the breast cancer. Similar to other cancer types, the gynecological cancer is the system disease, meaning that the malfunctions and mutations in the gene regulatory ...
Comparison of the Diagnostic Accuracy of Next Generation Sequencing and Microarray Resequencing Methods for Detection of BRCA1 and BRCA2 Gene Mutations Bahsi, Taha; Ergun, Sezen Güntekin; Ergun, Mehmet Ali; Perçin, E. Ferda (Gazi University, 2018-4-1) Objective: Breast cancer constitutes 29 % of estimated new cases of cancer in women, and it is also one of the major cause of death in all cancer types. In this study, DNA samples of familial breast cancer patients with BRCA1 and BRCA2 mutations which had been analyzed using conventional DNA sequencing method, were also analyzed with new methods including microarray and next generation sequencing (NGS) in order to compare their results Methods: Seven patients with BRCA1 mutation, one patient with BRCA2 m...
Modeling of Breast and Gynecological Cancers Data and Investigating New Biological Findings Ağyüz, Umut; Purutçuoğlu Gazi, Vilda (null; 2018-06-27) The breast and gynecological cancers are two most common fatal cancers’ types in women in the world [1]. In oncological literature, these two cancers types are typically worked together since they are the risk factors of each other if the patient has one of these diseases [2]. In general, the cancers, like the heart diseases, are the systems’ ilnesses in the sense that any malfunctions in the associated transaction pathways cause problems in the activation flow, resulting in tumors. Therefore, the mathemati...
Network-based discovery of molecular targeted agent treatments in hepatocellular carcinoma Fayetörbay, Rumeys; Tunçbağ, Nurcan; Department of Bioinformatics (2020) Hepatocellular carcinoma (HCC) is one of the most-deadly cancers and the most common type of primary liver cancer. Multikinase inhibitor Sorafenib is one of FDA approved targeted agents in HCC treatment. PI3K/AKT/mTOR pathway is altered in about 51% of HCC; hence, understanding how Sorafenib and PI3K/AKT/mTOR pathway inhibitors act at signaling level is crucial for targeted therapies and to reveal the off-target effects. In this work, we use gene expression profiles (GEPs) of HCC cells (Huh7 and Mahlavu) wh...
Structural mapping and network analysis of patient-specific mutations in glioblastoma Kaya, Tuğba; Tunçbağ, Nurcan; Doğan, Tunca; Department of Bioinformatics (2018) Cancer is one of the most common cause of death worldwide. It occurs as a result of a collection of somatic deviations from normal state. Therefore, many efforts have been invested to profile mutations in different types of tumors; such as, the Cancer Genome Atlas (TCGA) which deposits multiple omic data for more than 11,000 tumor samples. In this thesis, we present a pipeline which retrieves patient-specific mutation data in Glioblastoma from TCGA, maps these mutations on the protein structures in Protein ...

Citation Formats

B. S. Karakelle, “Analyses and modeling of ovarian cancer microarray data,” Thesis (M.S.) -- Graduate School of Natural and Applied Sciences. Biomedical Engineering., Middle East Technical University, 2019.